Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
- 1 October 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 91 (1) , 160-172
- https://doi.org/10.1016/s0090-8258(03)00434-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- MAPKs: new JNK expands the groupPublished by Elsevier ,2002
- Mammalian MAP kinase signalling cascadesNature, 2001
- MAP kinase pathways activated by stress: The p38 MAPK pathwayCritical Care Medicine, 2000
- The Hallmarks of CancerCell, 2000
- Organization and regulation of mitogen-activated protein kinase signaling pathwaysPublished by Elsevier ,1999
- Redox-Mediated Gene Therapies for Environmental Injury: Approaches and ConceptsAntioxidants and Redox Signaling, 1999
- Hyperexpression of mitogen-activated protein kinase in human breast cancer.Journal of Clinical Investigation, 1997
- Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signallingBiochemical Journal, 1996
- Acute hypertension activates mitogen-activated protein kinases in arterial wall.Journal of Clinical Investigation, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995